ILMN up +2.17% percent Today $ILMN High is at 191.56 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ILMN up +2.17% percent Today $ILMN High is at 191.56 and the Low 186.92 with current volume of 242,091.

Recent News posted below.

Illumina Inc ILMN other info.
http://investorshangout.com/Illumina-ILMN-54443/

ILMN Illumina Inc Recent Headline News

Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:40PM CST
Alnylam (ALNY) expands its hepatic infectious disease pipeline with two new candidates, ALN-HDV (hepatitis delta viral) and ALN-PDL (chronic liver).
BIIB: 320.91 (-0.11), ALNY: 102.35 (+2.50), ILMN: 190.70 (+3.78), AMAG: 34.96 (+0.03)

Brand Timbre Develops Audio-Identity Platform for World's Largest Genomics Company
Marketwired - Wed Nov 12, 6:00AM CST
Brand Timbre LLC, a strategic sonic branding agency, has completed work on the first stage of a comprehensive audio-branding initiative for Illumina Inc. Illumina is an industry-leading life-sciences company that designs, develops and manufactures DNA and genetics sequencing machines used in labs throughout the world. Brand Timbre's multi-phase project includes an audio-branding strategy, an audio-identity profile that defines Illumina's sound, an audio logo, and product-sonification (sound design) assets for Illumina's sequencing instruments.
ILMN: 190.70 (+3.78)

Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 13.67 (-1.08), AMD: 2.72 (+0.01), ACHN: 14.63 (-0.22), CLDX: 15.13 (+0.32), ILMN: 190.70 (+3.78)

Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 16.00 (unch), ACHN: 14.63 (-0.22), ILMN: 190.70 (+3.78), AFFX: 9.97 (+0.19)

Global Preimplantation Genetic Diagnosis (PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) Market - Trends and Forecast to 2020
M2 - Tue Nov 11, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sm76mf/preimplantation) has announced the addition of the "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring. This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles Companies Mentioned: - Genea Ltd. - Genesis Genetics - Illumina, Inc. - Laboratory Corporation of America Holdings (LabCorp) - Natera, Inc. - PerkinElmer, Inc. - Quest Diagnostics, Inc. - Reproductive Genetics Institute - Reprogenetics LLC For more information visit http://www.researchandmarkets.com/research/sm...plantation
DGX: 63.64 (+0.75), LH: 100.07 (-0.63), ILMN: 190.70 (+3.78), PKI: 43.76 (-0.02)

Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 11, 3:18AM CST
Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
CST: 41.27 (+0.87), JACK: 72.38 (+0.07), IHS: 131.03 (+0.17), ILMN: 190.70 (+3.78)

Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.19 (+0.48), VRX: 132.89 (+1.80), ALXN: 194.26 (+0.57), AMGN: 161.78 (-0.15), MYL: 55.12 (+1.32), ILMN: 190.70 (+3.78), CELG: 108.74 (+0.49)

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.33 (+0.13), HD: 99.14 (+0.65), AKRX: 37.01 (+1.58), ILMN: 190.70 (+3.78)

'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), ESV: 38.59 (-0.68), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.95 (-1.64)

Cramer's Lightning Round - Baxter May Go Faster (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday November 5. Bullish Calls: Baxter (NYSE: BAX ): "I think it is finally starting to run. It has lagged, but it is time to pull the...
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.97 (-1.62)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 244.48 (+3.86), LMT: 188.58 (+1.71), XOM: 94.84 (-0.54), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), KORS: 71.45 (+0.45), PAYX: 47.65 (+0.16), RIG: 26.76 (-0.32), EOG: 96.27 (-1.29), COST: 137.76 (+0.86), TWTR: 43.00 (+0.46), OXY: 86.97 (-1.62), KO: 43.03 (+0.32), SEAS: 16.91 (+0.06), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), TRIP: 71.29 (+0.91), DISCA: 31.99 (+0.13), CHUY: 22.37 (-0.12), LB: 77.09 (-0.85), GEO: 39.78 (-0.21), ESV: 38.59 (-0.68), MPC: 93.71 (-1.30), BAX: 72.10 (+0.77), MRK: 59.80 (+0.49), EXPE: 86.92 (-0.19), STI: 39.73 (-0.12)

SmarTrend Watching for Potential Rebound in Shares of Illumina After 2.63% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)

Illumina Falls 2.63% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.31 (-0.08), MNST: 108.63 (+0.72), SWKS: 61.19 (+0.20), GMCR: 152.59 (-0.14), ILMN: 190.70 (+3.78), WSM: 69.04 (+0.27), NXPI: 74.00 (+0.60), CELG: 108.74 (+0.49), HAIN: 107.50 (+0.81), AGN: 197.50 (+0.99), CNC: 97.34 (-0.16), V: 251.14 (-0.81), CALM: 41.77 (+0.03), JAZZ: 175.77 (+2.24), ALXN: 194.26 (+0.57), LOW: 58.65 (+0.43), ULTA: 124.69 (-0.35), MA: 84.25 (-0.10), AVGO: 87.47 (+0.42), PETM: 73.03 (+0.26)

Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 56.98 (+0.78), STJ: 66.07 (+0.39), ILMN: 190.70 (+3.78), PCRX: 91.39 (+1.98), WLP: 127.57 (+0.93)

Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 107.23 (+0.90), ONCY: 0.81 (-0.03), GERN: 2.39 (+0.02), ILMN: 190.70 (+3.78)

Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 233.90 (+2.77), ALXN: 194.26 (+0.57), ILMN: 190.70 (+3.78), REGN: 399.11 (-2.00), CRM: 64.02 (+0.25), CELG: 108.74 (+0.49)

Was That The Final Growth Stock Shakeout?
Cabot - Seeking Alpha - Mon Nov 03, 10:23AM CST
By Michael Cintolo, Chief Analyst, Cabot Market Letter Back in the fall of 1999, we attended a conference where one chart-focused investor gave a presentation we still remember to this day. Most investors remember 1999 as an endless party, but the...
SPY: 204.73 (+0.77), QQQ: 103.19 (+0.73), DIA: 176.82 (+0.78), ILMN: 190.70 (+3.78), IWM: 118.18 (+0.28), CELG: 108.74 (+0.49)

Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:39AM CST
Prosensa Holding N.V. (RNA) was a big mover last session, as its shares rose nearly 10% on the day.
MDVN: 107.23 (+0.90), MACK: 8.49 (-0.06), RNA: 11.79 (+0.04), ILMN: 190.70 (+3.78)

Illumina Inc. (ILMN) Stock Research Links

ILMN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Thanksgiving Dog Safety Is a Pet Care Reality Check

Updated Category News Views 0

A crowded Thanksgiving kitchen can turn a well-behaved dog into a scavenger with lousy odds. Camp Bow Wow’s holiday guidance is not pretending the meal itself is the problem; the trouble is that a house full of distracted people, rich food and unsecured trash creates a pile of easy mistakes. For pet owners, that is a fair reminder. For anybody watching the pet-care...

Continue Reading
Peptide Labels Cannot Substitute for Clinical Care

Updated Category News Views 9

A Label Is Not a Care Plan Those three little words, research use only, carry far more weight than a flashy product page would have people believe. The HelloNation article featuring wellness expert Andres Giraldo makes a plain but necessary distinction: a research-use-only, or RUO, label does not turn a peptide into prescribed treatment, and it sure does not establish...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 0

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 206

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Tactical Tomahawk Motor Deal Puts Propulsion in Focus

Updated Category News Views 31

A missile program lives or dies on unglamorous hardware, and solid rocket motors are about as unglamorous as it gets until somebody cannot build enough of them. Raytheon has awarded Ursa Major and Avio USA a joint contract to develop solid rocket motors for the U.S. Navy’s Tactical Tomahawk missile program. That is the whole headline, and it matters more than the thin...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 127

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 91

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Kawneer’s OptiQ Window Wins a Useful Design Signal

Updated Category News Views 49

Three Nods, One Very Practical Product Claim Windows rarely stir much excitement outside an architect’s specification binder, but Kawneer has put together a respectable run with its OptiQ Offset Fixed/Projected Series Window. On November 18, 2026, the architectural aluminum-systems maker said the product had won in the Windows and Doors category at both the 2026...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 157

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 46

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie's Options Activity: Understanding the Market Trends

Updated Category News Views 188

Understanding AbbVie’s Recent Options Activity Recently, there has been a notable shift in the options trading landscape surrounding AbbVie (NYSE: ABBV). Investors with significant capital seem to be leaning towards a bearish outlook regarding AbbVie. This movement in options trading is particularly important for retail traders to consider. What’s Behind the Trading...

Continue Reading
Innovative Trends at Spielwarenmesse: A Toy Industry Showcase

Updated Category News Views 271

Exploring the Spielwarenmesse: The Ultimate Toy Expo The Spielwarenmesse has established itself as a pivotal platform for the global toy industry. Showcasing creativity, innovation, and networking opportunities, this event gathers notable participants from across the toy spectrum. Diverse Exhibitors and Cutting-Edge Innovations With over 2,362 exhibitors representing 71...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 173

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Bureau Veritas Expands in Renewables with ArcVera Acquisition

Updated Category News Views 74

Bureau Veritas Expands in the Renewable Energy Sector Bureau Veritas, a global leader in testing, inspection, and certification services, has recently made a significant move by acquiring ArcVera Renewables. This strategic acquisition aims to strengthen Bureau Veritas's position in the fast-growing renewable energy sector across North America. Strategic Alignment with...

Continue Reading
Understanding T. Rowe Price Group's Earnings Expectations

Updated Category News Views 170

Anticipating T. Rowe Price Group's Earnings Announcement T. Rowe Price Gr (TROW) is poised to announce its quarterly earnings soon. Investors are keenly focused on the impending announcement, hoping for positive results that exceed expectations. As the company prepares for the reporting date, understanding what to anticipate can be essential for informed investment...

Continue Reading